Coherus BioSciences Inc (CHRS)
2.02
-0.16
(-7.34%)
USD |
NASDAQ |
Apr 24, 16:00
2.025
0.00 (0.00%)
After-Hours: 20:00
Coherus BioSciences Free Cash Flow (Quarterly): -12.97M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -12.97M |
September 30, 2023 | -54.30M |
June 30, 2023 | -39.02M |
March 31, 2023 | -68.88M |
December 31, 2022 | -100.04M |
September 30, 2022 | -37.55M |
June 30, 2022 | -50.92M |
March 31, 2022 | -54.66M |
December 31, 2021 | -52.79M |
September 30, 2021 | 13.45M |
June 30, 2021 | -0.603M |
March 31, 2021 | 1.222M |
December 31, 2020 | 32.17M |
September 30, 2020 | 45.24M |
June 30, 2020 | 57.81M |
March 31, 2020 | 11.69M |
December 31, 2019 | 17.32M |
September 30, 2019 | 54.03M |
June 30, 2019 | 12.50M |
March 31, 2019 | -57.32M |
Date | Value |
---|---|
December 31, 2018 | -47.58M |
September 30, 2018 | -43.28M |
June 30, 2018 | -35.54M |
March 31, 2018 | -33.66M |
December 31, 2017 | -30.03M |
September 30, 2017 | -43.32M |
June 30, 2017 | -56.54M |
March 31, 2017 | -74.97M |
December 31, 2016 | -90.46M |
September 30, 2016 | -62.45M |
June 30, 2016 | -27.69M |
March 31, 2016 | -78.46M |
December 31, 2015 | 4.123M |
September 30, 2015 | -62.05M |
June 30, 2015 | -21.85M |
March 31, 2015 | -34.38M |
December 31, 2014 | -33.77M |
September 30, 2014 | -5.977M |
June 30, 2014 | -1.51M |
March 31, 2014 | 14.48M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-100.04M
Minimum
Dec 2022
57.81M
Maximum
Jun 2020
-11.91M
Average
-0.603M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
AbbVie Inc | 4.548B |
Inovio Pharmaceuticals Inc | -26.28M |
Nektar Therapeutics | -47.28M |
Avid Bioservices Inc | -1.224M |
Stereotaxis Inc | -2.439M |